Stocktoria
Ingevity Corp NGVT
NYSE · XNYS · stock · Chemicals & Allied Products · website · IPO 2016-05-02
Ingevity Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 39.5% | 38.7% | 36.6% | 34.2% | 36.9% |
| Operating margin | 35.9% | 35.5% | 34.8% | 27.1% | 30.3% |
| Net margin | -14.3% | -35.9% | -0.4% | 12.7% | 8.5% |
| Return on assets | -10.1% | -21.3% | -0.2% | 7.7% | 4.8% |
| Return on equity | -562.6% | -220.4% | -0.9% | 30.3% | 17.5% |
| Current ratio | 1.33 | 1.87 | 1.81 | 2.25 | 2.70 |
| Revenue growth | -2.7% | -1.3% | -27.1% | 19.9% | 14.4% |
Source: SEC EDGAR filings · CIK 0001653477 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.